Posts

Archives

MANUFACTURING, BLOG

The Future of Factory-Floor Efficiency: Strategies, Trends, and Actionable Insights

In today’s rapidly evolving manufacturing landscape, industry leaders are implementing innovative solutions to drive efficiency, safety, and sustainability on the plant floor. From leveraging advanced automation and digital technologies to fostering a culture of continuous improvement, manufacturers are rethinking traditional processes to improve productivity and respond to growing environmental and workforce expectations. Key trends like predictive maintenance, enhanced worker safety protocols, and the shift toward greener practices highlight a renewed focus on creating smarter, safer, and more adaptable factories. This article explores the latest strategies and actionable insights from top executives, shedding light on how the future of manufacturing is being reshaped one improvement at a time.

Continue reading
BLOG

Ideas and Innovations on Mentoring, Sponsoring, and Reverse-Mentoring

As I write this, Executive Platforms organizes events for senior leaders relating to Pharmaceutical and Biopharmaceutical Manufacturing, supply chains in both North America and Europe, Technology, Human Resources, Finance, Food Safety and Quality, Sustainability, and Manufacturing. It is surprisingly easy to find common issues and challenges that people in positions of authority in these different roles have in common not just within their own disciplines, but across sectors. At some point as you rise through an organization, the specifics of your profession must include universals about leadership and people. You can have a conversation about a leader’s responsibilities and soft…

Continue reading
BLOG, LIFE SCIENCES

A Focus on the Fundamentals During the Fastest Growth in the History of Pharmaceutical Manufacturing

How fast is too fast when we are talking about the future of medicine? This is not a new question, but it is being asked at a time of unprecedented change and at the tipping point of a whole new generation of products starting to enter commercialization. Between Cell and Gene Therapy, mRNA vaccine technology, and the full width and breadth of other R&D efforts across the pharmaceutical and biopharmaceutical space, the drug development pipeline has grown from 11 to 21 percent since the global pandemic with no sign of slowing down. All this is happening during a time of…

Continue reading